How Much Does Mounjaro Cost in 2026? A Pricing Breakdown

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where GLP-1 pharmacology, weight-management protocols, and the genetic variables underneath them are explained in plain language. Browse the full Peptides & GLP-1 library.

How much does Mounjaro cost in 2026? It is one of the most-searched GLP-1 questions, and the numbers people quote online swing wildly because they are describing different situations. This breakdown snapshots the current price picture — list price, coverage, discounts, and compounded alternatives — so you can tell which figure applies to you.

The 2026 price picture

There is no single Mounjaro price in 2026. What you pay is assembled from your insurance coverage, the FDA-approved indication on your prescription, savings-card eligibility, your pharmacy, and whether a compounded alternative is available through a licensed pathway. Understanding those inputs is the only way to read a quoted price correctly.

List price and why it is the ceiling

Mounjaro's list price is approximately $1,069 per month at U.S. list as of April 2026, per Eli Lilly's published pricing. That figure is the ceiling, not the norm — it is the number before insurance, rebates, manufacturer savings cards, and pharmacy negotiation apply. Most insured patients never pay list in full, which is exactly why quoted prices scatter so widely.

Coverage: commercial versus Medicare

Commercial plan coverage depends on whether the prescription is for an FDA-approved indication and on the plan's formulary and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; coverage for chronic weight management is more variable, often gated by BMI-based prior authorization, and excluded entirely by some plans. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Confirm directly with your plan.

Cutting the cost: cards and coupons

Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps that change — verify current terms at fill. Independent discount platforms such as GoodRx and SingleCare publish coupon prices that vary by pharmacy.

Compounded alternatives after the shortage

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing but not eliminating legitimate compounding activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified; they are not identical to the FDA-approved brands and are priced separately. In practice, one realistic scenario is a commercially-insured patient with the indication covered and a savings card applied paying as little as $25 per month, while an uninsured patient approaches list price.

Genetics as a cost-of-decision tool

A pricey, ongoing therapy is a decision worth informing before you spend. Variants in FTO (appetite set-point), MC4R (satiety and energy balance), and TCF7L2 (glucose handling and GLP-1 secretion) shape your metabolic baseline. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights as trait and pathway education. It never predicts response to a specific medication — it is upstream context you can bring to a provider, alongside the PlexusDx Weight Management Protocols.

Reading a quoted price correctly

When you see a Mounjaro price online, ask three questions before you trust it: what coverage did that person have, which indication was on their prescription, and what coupon or savings card were they using? The same drug can be as little as $25 for one patient and near list for another, and neither figure is wrong, they simply describe different situations. Anchoring to the list-price ceiling and then subtracting the levers that actually apply to you is the only way to arrive at a number you can plan around.

Prices in this category also shift over time as coverage policies, savings-program terms, and compounding rules evolve, so a figure that is accurate in April 2026 may not hold six months later. Re-check the specifics at the point of fill rather than trusting an older quote you saw online.

Frequently Asked Questions

How much does Mounjaro cost in 2026?

List price is approximately $1,069 per month at U.S. list as of April 2026, per Eli Lilly's published pricing. What you actually pay depends on insurance coverage, the indication on your prescription, savings cards, and your pharmacy. Verify the current price before filling.

Why do online prices vary so much?

Because each quoted figure describes a different situation — a specific plan, pharmacy, coupon, and indication on a particular day. List price is the ceiling, and insurance, savings cards, and compounded alternatives pull the real cost down from there in ways that differ person to person.

Can I pay as little as $25 a month?

Some eligible commercially-insured patients pay as little as $25 per month when their plan covers the indication and a manufacturer savings card applies, subject to caps. Government-insurance patients are generally excluded, so that figure will not apply to every situation.

Are compounded versions a cheaper alternative?

Licensed 503A compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from the branded product. These are not generics and not identical to the brand. PlexusDx publishes per-protocol pricing on each Weight Management Protocols product page, and whether a compounded option fits is a clinical decision to make with a provider.

Keep reading inside the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.